UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma
BackgroundLung adenocarcinoma (LUAD) represents a significant global health burden. The absence of reliable biomarkers and the heterogeneity in treatment responses continue to hinder improvements in patient prognosis. This study aimed to identify novel…